Behavioral and Social Research Funding Opportunities and Applicant Resources
- Time-Limited Funding Opportunities
- BSR Opportunities in AD/ADRD
- Current Funding Opportunities
- Research and Funding FAQs
Time-Limited Funding Opportunities
Time-limited FOAs typically have a single due date and a special allocation of funds. BSR is accepting grant applications to a number of time-limited funding opportunities in different scientific domains related to aging, AD/ADRD, and COVID-19 research. Please see below for current time-limited funding opportunities.
| FOA Number | Title | Focus | Release Date | Final Due Date |
|---|---|---|---|---|
| NOT-AG-22-022 |
NIA anticipates committing up to $15,000,000 for meritorious administrative supplement applications to NIA and other participating IC parent grants |
AD/ADRD | 6/1/2022 | 7/6/2022 |
| RFA-AG-23-005 |
NIA intends to commit $2 million in FY 2023 to fund 6 awards. |
AD/ADRD | 2/17/2022 | 7/1/2022 |
| RFA-AG-23-003 |
NIA intends to commit $1,600,000 in FY 2023 to fund 1 award. |
Aging | 12/20/2021 | 7/1/2022 |
| RFA-AG-23-007 |
Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional) NIA intends to commit $1,280,000 in FY 2023 to fund 1 award. Future year awards will depend on NIA appropriations, but NIA also intends to commit $1,760,000 in FY 2024; $2,048,000 in FY 2025; $2,816,000 in FY 2026; and $2,816,000 in FY 2027. |
AD/ADRD | 2/23/2022 | 7/11/2022 |
| RFA-MH-22-135 |
Social Disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) NIA intends to commit a total of $2,000,000 in FY 2023 to fund 4-6 awards for this FOA and the companion FOA, RFA-MH-22-136. |
AD/ADRD | 12/23/2021 | 10/15/2022 |
| RFA-MH-22-136 |
Social Disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) NIA intends to commit a total of $2,000,000 in FY 2023 to fund 4-6 awards for this FOA and the companion FOA, RFA-MH-22-136. |
AD/ADRD | 12/23/2021 | 10/15/2022 |
| RFA-AG-23-022 |
NIA intends to commit $3,960,000 in fiscal year 2023 to fund up to 6 awards. |
AD/ADRD | 6/9/2022 |
10/20/2022 |
| RFA-AG-23-023 |
NIA intends to commit $1,361,500 in fiscal year 2023 to fund up to 6 awards. |
AD/ADRD | 6/9/2022 | 10/20/2022 |
| RFA-AG-23-024 |
NIA intends to commit $4,500,000 in FY 2023 to fund 5-6 awards. |
AD/ADRD | 5/6/2022 | 10/20/2022 |
BSR Opportunities in AD/ADRD
Parent Funding Opportunities and Associated NOSIs
NIA has two parent funding opportunities that invite applications on a variety of Alzheimer’s disease and Alzheimer's disease related dementias research topics. PAR-22-093 is for R01 applications and PAR-22-094 is for R21 applications. Notices of Special Interest associated with these parent FOAs specify high priority behavioral and social research topics and are listed below.
Major Opportunities in AD/ADRD Research
In addition to the parent AD/ADRD funding opportunities, BSR participates in other announcements aimed specifically at building AD/ADRD research infrastructure, developing clinical trials, and more. AD/ADRD research is also included in many other announcements in which BSR participates, detailed in the Current Funding Opportunities section below.
Current Funding Opportunities
BSR is accepting grant applications to a number of funding opportunities in different scientific domains related to aging, AD/ADRD, and COVID-19 research. Please see below for current funding opportunities.
The full list of NIA-wide active funding opportunities and NIA-wide AD/ADRD funding opportunities can also be found online.
Research & Funding FAQs
Access frequently asked questions related to NIA research and funding.
